IP Library Granted Patent US 9,392,945
Granted Patent B2
US 9,392,945 · App. 13/733,782 · Granted Jul 19, 2016

Automated CCHD screening and detection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,392,945
App. No.
13/733,782
Granted
Jul 19, 2016
Kind
B2
Abstract

Automated critical congenital heart defect (“CCHD”) screening systems and processes are described. A caregiver may be guided to use a single or dual sensor pulse oximeter to obtain pre- and post-ductal blood oxygenation measurements. A delta of the measurements indicates the possible existence or nonexistence of a CCHD. Errors in the measurements are reduced by a configurable measurement confidence threshold based on, for example, a perfusion index. Measurement data may be stored and retrieved from a remote data processing center for repeated screenings.

Claims (43)

1. A method of detecting a critical congenital heart defect using a pulse oximeter, the method comprising:

instructing a caregiver, using a display of a pulse oximeter, to position a noninvasive sensor to a first measurement site predetermined to be indicative of a pre-ductal blood oxygenation level, wherein said noninvasive sensor is configured to output signals responsive to attenuation of light at measurement sites on a patient, and wherein said pulse oximeter is in communication with the noninvasive sensor to drive light sources of said noninvasive sensor and receive said output signals;

receiving, during a first duration of time, said output signals to obtain a first waveform responsive to a pre-ductal oxygen saturation of the patient, said first duration of time corresponding to when said noninvasive sensor is positioned at said first measurement site;

instructing the caregiver, using the display of the pulse oximeter, to position said noninvasive sensor to a second measurement site predetermined to be indicative of a post-ductal blood oxygenation level;

receiving, during a second duration of time, said output signals to obtain a second waveform responsive to a post-ductal oxygen saturation of the patient, said second duration of time corresponding to when said noninvasive sensor is positioned at said second measurement site;

electronically determining, by one or more signal processors, one or more waveform features in said first waveform responsive to said pre-ductal oxygen saturation;

electronically determining, by the one or more signal processors, one or more of said one or more waveform features in said second waveform responsive to said post-ductal oxygen saturation;

electronically time-wise aligning, by the one or more signal processors, one or more of said one or more waveform features from said first waveform with one or more of said one or more waveform features from said second waveform;

electronically determining, by the one or more signal processors, a pre-ductal value of said first waveform at a first time;

electronically determining, by the one or more signal processors, a post-ductal value of said second waveform at said first time taking into account said time-wise aligning; and

in response to determining said pre-ductal value and said post-ductal value differ by a predetermined threshold, outputting display indicia to said display indicating a likelihood that said patient has said critical congenital heart defect.

2. The method of claim 1 , wherein said first time comprises a third duration of time, and wherein determining said pre-ductal value and said post-ductal value differ by the predetermined threshold comprises:

calculating an average difference between said pre-ductal value and said post-ductal value over the third duration of time.

3. The method of claim 2 , wherein said first duration of time and said second duration of time each comprise at least sixty seconds.

4. The method of claim 3 , wherein said third duration of time comprises at least thirty seconds.

5. The method of claim 1 , wherein said one or more waveform features from said first waveform comprise at least one of: a trough, a peak, a natural high cycle of oxygen saturation, a natural low cycle of oxygen saturation, or a cyclical variation.

6. The method of claim 1 further comprising:

discarding a waveform when a quality of said output signals is outside of a pre-determined range.

7. The method of claim 1 further comprising:

receiving said signal outputs to obtain a third waveform responsive to a blood perfusion level of the patient, wherein a waveform discarded when the blood perfusion level associated with the waveform is outside of a pre-determined range.

8. A pulse oximetry based system configured to detect a critical congenital heart defect, the system comprising:

a noninvasive sensor configured to output signals responsive to an attenuation of light at measurement sites on a patient; and

a pulse oximeter in communication with the noninvasive sensor to drive light sources of said noninvasive sensor and to receive said output signals, said pulse oximeter including one or more signal processors, the signal processors configured to:

instruct a caregiver, using a display of the pulse oximeter, to position said noninvasive sensor to a first measurement site predetermined to be indicative of a pre-ductal blood oxygenation level;

receive, during a first duration of time, said output signals to obtain a first waveform responsive to a pre-ductal oxygen saturation of the patient, said first duration of time corresponding to when said noninvasive sensor is positioned at said first measurement site;

instruct the caregiver, using the display of the pulse oximeter, to position said noninvasive sensor to a second measurement site predetermined to be indicative of a post-ductal blood oxygenation level;

receive, during a second duration of time, said output signals to obtain a second waveform responsive to a post-ductal oxygen saturation of the patient, said second duration of time corresponding to when said noninvasive sensor is positioned at said second measurement site;

electronically determine one or more waveform features in said first waveform responsive to said pre-ductal oxygen saturation;

electronically determine one or more of said one or more waveform features in said second waveform responsive to said post-ductal oxygen saturation;

electronically time-wise align one or more of said one or more waveform features from said first waveform with one or more of said one or more waveform features from said second waveform;

electronically determine a pre-ductal value of said first waveform at a first time;

electronically determine a post-ductal value of said second waveform at said first time taking into account said time-wise aligning; and

in response to determining said pre-ductal value and said post-ductal value differ by a predetermined threshold, output display indicia to said display indicating a likelihood that said patient has said critical congenital heart defect.

9. The system of claim 8 , wherein said first time comprises a third duration of time, and wherein determining said pre-ductal value and said post-ductal value differ by the predetermined threshold comprises:

calculating an average difference between said pre-ductal value and said post-ductal value over the third duration of time.

10. The system of claim 9 , wherein said first duration of time and said second duration of time each comprise at least sixty seconds.

11. The system of claim 10 , wherein said third duration of time comprises at least thirty seconds.

12. The system of claim 8 , wherein said one or more waveform features from said first waveform comprise at least one of: a trough, a peak, a natural high cycle of oxygen saturation, a natural low cycle of oxygen saturation, or a cyclical variation.

13. The system of claim 8 , wherein the signal processors are further configured to:

discard a waveform when a quality of said output signals is outside of a pre-determined range.

14. The system of claim 8 , wherein the signal processors are further configured to:

receive said signal outputs to obtain a third waveform responsive to a blood perfusion level of the patient; and

discard a waveform when the blood perfusion level associated with the waveform is outside of a pre-determined range.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Nov 7, 2018
From: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION
To: MASIMO AMERICAS, INC.; MASIMO CORPORATION
Reel/Frame 047443/0109 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED AT REEL: 032784 FRAME: 0864. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded May 27, 2014
From: MASIMO AMERICAS, INC.; MASIMO CORPORATION
To: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION
Reel/Frame 033032/0426 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2014
From: MASIMO CORPORATION; MASIMO AMERICAS, INC.
To: JPMORGAN CHASE BANK, NATIONAL ASSOCIATION
Reel/Frame 032784/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2013
From: AL-ALI, AMMAR; MUHSIN, BILAL
To: MASIMO CORPORATION
Reel/Frame 030077/0573 →